Advertisement
Hemlibra (emicizumab-kxwh) has been approved by the U.S. Food and Drug Administration to prevent or reduce the frequency of bleeding episodes among hemophilia A patients with Factor VIII inhibitors.

FDA OKs Drug for Hemophilia A With Factor VIII Inhibitors

0
Weekly prophylactic treatment associated with substantial decrease in bleeding episodes
A simple

Simple Checklist Can Identify Useful Clinical Practice Guidelines

0
Eight-item tool developed for clinicians to identify trustworthy, useful, and relevant guidelines
More than 40 percent of health care personnel with influenza-like illness work while ill

Many Health Care Providers Work While Sick

0
Pharmacists and physicians have the highest frequency of working with influenza-like illness
Metastatic castration-resistant prostate cancer has heterogeneity in positron emission tomography/computed tomography imaging phenotype

Heterogeneity of PET/CT Imaging Phenotype Prognostic in mCRPC

0
Assessments of androgen receptor, glycolysis prognostic in castration-resistant prostate Cancer
Sentinel lymph node biopsy is underused for high-risk squamous cell carcinoma of the skin

Sentinel Lymph Node Biopsy Underused in High-Risk SCC

0
<0.1 percent of patients with high-risk SCC tumors underwent SLNB; 14 percent underwent dissections
In patients with progressive glioblastoma

Drug Combo Doesn’t Lengthen Glioblastoma Survival

0
Lomustine+bevacizumab may increase progression-free, but not overall, survival versus lomustine alone
Health care experts are supportive of OurNotes

Health Care Experts in Favor of Patient Contribution to Notes

0
With some cautions, experts are supportive of the OurNotes medical notes intervention
Insurance coverage differences account for about half of the disparity in survival rates between black and white patients aged 18 to 64 years with colorectal cancer

Insurance Underlies Black-White Survival Disparity in CRC

0
54 percent of excess risk of death in black colorectal cancer patients accounted for by insurance matching
African-American women with type 2 diabetes appear to be at increased risk of developing estrogen receptor-negative (ER-) breast cancer

ER- Breast CA Risk Up for African-Americans With T2DM

0
ER- type accounts for increased breast cancer risk in African-American women; highest risk in nonobese
Fewer than half of younger adults with colorectal cancer undergo mismatch repair deficiency of DNA testing

Use of MMR Deficiency Testing in Younger CRC Patients Is Low

0
Just 43.1 percent underwent mismatch repair deficiency of DNA testing